vs
Side-by-side financial comparison of Claritev Corp (CTEV) and LifeStance Health Group, Inc. (LFST). Click either name above to swap in a different company.
LifeStance Health Group, Inc. is the larger business by last-quarter revenue ($382.2M vs $246.6M, roughly 1.6× Claritev Corp). LifeStance Health Group, Inc. runs the higher net margin — 3.1% vs -32.7%, a 35.7% gap on every dollar of revenue. On growth, LifeStance Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs 6.2%). LifeStance Health Group, Inc. produced more free cash flow last quarter ($46.6M vs $36.4M). Over the past eight quarters, LifeStance Health Group, Inc.'s revenue compounded faster (12.8% CAGR vs 2.5%).
Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.
CTEV vs LFST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $246.6M | $382.2M |
| Net Profit | $-80.6M | $11.7M |
| Gross Margin | — | — |
| Operating Margin | -3.1% | 4.7% |
| Net Margin | -32.7% | 3.1% |
| Revenue YoY | 6.2% | 17.4% |
| Net Profit YoY | 41.6% | 264.1% |
| EPS (diluted) | $-4.88 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $246.6M | $382.2M | ||
| Q3 25 | $246.0M | $363.8M | ||
| Q2 25 | $241.6M | $345.3M | ||
| Q1 25 | $231.3M | $333.0M | ||
| Q4 24 | $232.1M | $325.5M | ||
| Q3 24 | $230.5M | $312.7M | ||
| Q2 24 | $233.5M | $312.3M | ||
| Q1 24 | $234.5M | $300.4M |
| Q4 25 | $-80.6M | $11.7M | ||
| Q3 25 | $-69.8M | $1.1M | ||
| Q2 25 | $-62.6M | $-3.8M | ||
| Q1 25 | $-71.3M | $709.0K | ||
| Q4 24 | $-138.0M | $-7.1M | ||
| Q3 24 | $-391.4M | $-6.0M | ||
| Q2 24 | $-576.7M | $-23.3M | ||
| Q1 24 | $-539.7M | $-21.1M |
| Q4 25 | -3.1% | 4.7% | ||
| Q3 25 | 4.1% | 2.0% | ||
| Q2 25 | 6.9% | -0.9% | ||
| Q1 25 | 4.2% | 0.5% | ||
| Q4 24 | -17.8% | 0.3% | ||
| Q3 24 | -146.7% | 0.0% | ||
| Q2 24 | -224.4% | -5.1% | ||
| Q1 24 | -207.4% | -5.6% |
| Q4 25 | -32.7% | 3.1% | ||
| Q3 25 | -28.4% | 0.3% | ||
| Q2 25 | -25.9% | -1.1% | ||
| Q1 25 | -30.8% | 0.2% | ||
| Q4 24 | -59.4% | -2.2% | ||
| Q3 24 | -169.8% | -1.9% | ||
| Q2 24 | -247.0% | -7.5% | ||
| Q1 24 | -230.1% | -7.0% |
| Q4 25 | $-4.88 | — | ||
| Q3 25 | $-4.23 | — | ||
| Q2 25 | $-3.81 | — | ||
| Q1 25 | $-4.38 | — | ||
| Q4 24 | $-8.49 | — | ||
| Q3 24 | $-24.25 | — | ||
| Q2 24 | $-35.78 | — | ||
| Q1 24 | $-33.40 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $16.8M | $248.6M |
| Total DebtLower is stronger | $4.6B | $282.8M |
| Stockholders' EquityBook value | $-173.9M | $1.5B |
| Total Assets | $4.9B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.8M | $248.6M | ||
| Q3 25 | $39.2M | $203.9M | ||
| Q2 25 | $56.4M | $188.9M | ||
| Q1 25 | $23.1M | $134.3M | ||
| Q4 24 | $16.8M | $154.6M | ||
| Q3 24 | $86.6M | $102.6M | ||
| Q2 24 | $48.8M | $87.0M | ||
| Q1 24 | $58.7M | $49.5M |
| Q4 25 | $4.6B | $282.8M | ||
| Q3 25 | $4.5B | $284.6M | ||
| Q2 25 | $4.5B | $286.4M | ||
| Q1 25 | $4.5B | $288.2M | ||
| Q4 24 | $4.5B | $290.0M | ||
| Q3 24 | $4.5B | $287.3M | ||
| Q2 24 | $4.5B | $288.0M | ||
| Q1 24 | $4.5B | $288.8M |
| Q4 25 | $-173.9M | $1.5B | ||
| Q3 25 | $-101.8M | $1.5B | ||
| Q2 25 | $-39.9M | $1.5B | ||
| Q1 25 | $14.8M | $1.5B | ||
| Q4 24 | $84.0M | $1.4B | ||
| Q3 24 | $207.6M | $1.4B | ||
| Q2 24 | $603.4M | $1.4B | ||
| Q1 24 | $1.2B | $1.4B |
| Q4 25 | $4.9B | $2.2B | ||
| Q3 25 | $5.0B | $2.1B | ||
| Q2 25 | $5.1B | $2.1B | ||
| Q1 25 | $5.1B | $2.1B | ||
| Q4 24 | $5.2B | $2.1B | ||
| Q3 24 | $5.3B | $2.1B | ||
| Q2 24 | $5.7B | $2.1B | ||
| Q1 24 | $6.4B | $2.1B |
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | 304.87× | 0.20× | ||
| Q4 24 | 53.67× | 0.20× | ||
| Q3 24 | 21.73× | 0.20× | ||
| Q2 24 | 7.48× | 0.20× | ||
| Q1 24 | 3.85× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $66.3M | $57.6M |
| Free Cash FlowOCF − Capex | $36.4M | $46.6M |
| FCF MarginFCF / Revenue | 14.8% | 12.2% |
| Capex IntensityCapex / Revenue | 12.1% | 2.9% |
| Cash ConversionOCF / Net Profit | — | 4.93× |
| TTM Free Cash FlowTrailing 4 quarters | $-12.3M | $110.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $66.3M | $57.6M | ||
| Q3 25 | $19.9M | $27.3M | ||
| Q2 25 | $61.2M | $64.4M | ||
| Q1 25 | $-30.1M | $-3.1M | ||
| Q4 24 | $-33.4M | $62.3M | ||
| Q3 24 | $72.8M | $22.7M | ||
| Q2 24 | $18.5M | $44.1M | ||
| Q1 24 | $49.7M | $-21.8M |
| Q4 25 | $36.4M | $46.6M | ||
| Q3 25 | $-16.3M | $17.0M | ||
| Q2 25 | $36.6M | $56.6M | ||
| Q1 25 | $-68.9M | $-10.3M | ||
| Q4 24 | $-63.8M | $56.0M | ||
| Q3 24 | $41.1M | $17.7M | ||
| Q2 24 | $-7.0M | $39.0M | ||
| Q1 24 | $19.2M | $-26.9M |
| Q4 25 | 14.8% | 12.2% | ||
| Q3 25 | -6.6% | 4.7% | ||
| Q2 25 | 15.2% | 16.4% | ||
| Q1 25 | -29.8% | -3.1% | ||
| Q4 24 | -27.5% | 17.2% | ||
| Q3 24 | 17.8% | 5.7% | ||
| Q2 24 | -3.0% | 12.5% | ||
| Q1 24 | 8.2% | -9.0% |
| Q4 25 | 12.1% | 2.9% | ||
| Q3 25 | 14.7% | 2.8% | ||
| Q2 25 | 10.2% | 2.2% | ||
| Q1 25 | 16.8% | 2.2% | ||
| Q4 24 | 13.1% | 1.9% | ||
| Q3 24 | 13.8% | 1.6% | ||
| Q2 24 | 10.9% | 1.6% | ||
| Q1 24 | 13.0% | 1.7% |
| Q4 25 | — | 4.93× | ||
| Q3 25 | — | 25.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -4.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
